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The present study investigated for the first time the incidence of childhood leukaemia (1990–2001) around French nuclear
installations using a geographic zoning based on estimated doses to the red bone marrow due to gaseous radioactive discharges. The
observed number of cases of acute leukaemia (O¼750) in 40km
2 centred on 23 French nuclear installations between 1990 and
2001 was lower than expected (E¼795.01), although not significantly so (standardised incidence ratio SIR¼0.94, 95% confidence
interval¼(0.88–1.01)). In none of the five zones defined on the basis of the estimated doses was the SIR significantly 41. There was
no evidence of a trend in SIR with the estimated doses for all the children or for any of the three age groups studied. This study
confirmed that there was no evidence of an increased incidence of childhood leukaemia around the 23 French nuclear sites.
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The epidemiological studies of leukaemia around nuclear sites
have analysed incidence with respect to the distance from the
plants, without considering details on the levels or geographic
distribution of the radiation dose due to discharges from the plants
(Laurier and Bard, 1999; Laurier et al, 2002). Such an approach
may lead to inappropriate grouping of areas studied, since the
dispersion of radionuclides is generally not isotropic and does not
decrease linearly with the distance, while the dose levels are not
equal for all sites. The present study investigated for the first time
the incidence of childhood leukaemia (1990–2001) around French
nuclear installations using a geographic zoning based on estimated
doses to the red bone marrow (RBM) due to gaseous radioactive
discharges.
In France, the levels of environmental contamination are
generally below detection limits of routine monitoring. Doses
therefore have to be estimated from discharge monitoring data and
mathematical modelling of radionuclide transfer in the environ-
ment. This approach is used for regulatory purposes, to estimate
doses to critical groups of the population, in the context of the
discharge authorisation procedure (Chartier et al, 2002). In this
paper, the approach has been adapted in order to estimate the
geographic distribution of doses due to gaseous discharges in
40km
2 centred on 24 nuclear installations in France and derive a
spatial zoning based on dose level order of magnitude. Beyond
20km from the sites, the doses become extremely low.
A previous study of the incidence of leukaemia around all
French nuclear installations found neither evidence of an overall
increased incidence of childhood leukaemia in the vicinity of the
29 main nuclear installations during 1990–1998 nor a trend in
standardised incidence ratio (SIR) with increasing distance from
the sites for all children under 15 years of age (White-Koning et al,
2004). Compared to this study, the present study includes three
additional years of observation (1990–2001).
SUBJECTS AND METHODS
Observed numbers of cases
The cases were all children under 15 years of age diagnosed with
leukaemia between 1st January 1990 and 31st December 2001 and
living around nuclear sites at the time of diagnosis. The cases were
provided by the French National Registry of Childhood Leukemia
and Lymphoma, which registered 5330 cases of acute leukaemia
from 1990 to 2001 for the mainland France (Clavel et al, 2004).
Eighty-one per cent of all the cases of acute leukaemia were acute
lymphoblastic leukaemia (ALL) and 17% were acute myeloid
leukaemia (AML). The incidence of acute leukaemia among
children aged o15 years varies markedly with age (Clavel et al,
2004). In particular, ALL incidence shows a typical peak at age
2 years for girls and 3 for boys. Therefore, the analyses were also
performed by age group (0–4, 5–9 and 10–14 years).
The Chooz and Civaux nuclear power plants were connected to
the grid in 1997 and 1999, respectively. Therefore, the childhood
leukaemia cases around those two sites were taken into account
from 1997 for Chooz and 1999 for Civaux.
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Age- and gender-specific population counts by ‘commune’ (the
smallest French administrative division), were derived from the
national censuses of March 1990 and March 1999 provided by the
National Institute for Statistics and Economic Studies (INSEE). A
‘de ´partement’ is an administrative geographic unit including 383
‘communes’ on average. The annual number of births by gender for
each ‘commune’ and the annual age- and gender-specific popula-
tion estimates for each ‘de ´partement’ were available for each year
from 1990 to 2001 (INSEE). They were used to obtain age- and
gender-specific population estimates from 1991 to 1998 and for
years 2000 and 2001 for each ‘commune’. The number of person
years for a given year and a given ‘commune’ were subsequently
calculated using those estimates. National age- and gender-specific
incidence rates for childhood leukaemia in France (1990–2001),
based on the National Registry data, were used as reference rates to
derive annual expected numbers of cases for each age group and
‘commune’ near nuclear sites. The annual expected numbers of
cases were used to estimate SIR defined as the ratio of the observed
over the expected number of cases. The exact 95% confidence
intervals (95% CI) for these ratios were given using a Poisson
distribution.
Exposure assessment
The spatial distribution of the exposure of the population around
French nuclear installations due to gaseous radioactive discharge
has been assessed by the Institute for Radiation Protection and
Nuclear Safety (IRSN) using radionuclide discharge data, local
climate data, and a mathematical model of nuclide transfers in the
environment (Morin and Backe, 2002, 2003). Four types of
installations were selected: nuclear power plants (NPP), nuclear
fuel cycle plants (one fuel production facility, one site with a fuel
conversion facility and a fuel enrichment facility), a nuclear fuel
reprocessing plant, and two research centres. All the 19 French
NPPs have been taken into account. They include two to six
reactors ranging from 900 electric megaWatts (MW) to 1450MW.
For plants of other types (nuclear fuel cycle plants, nuclear fuel-
reprocessing plant, research centres), only a few sites were selected
to test the feasibility of the approach and its consistency with the
available data. The selected nuclear fuel cycle plants include the
nuclear fuel processing plant at Romans-sur-Ise `re and the fuel
conversion plant and the fuel-enrichment plant at Pierrelatte. Two
nuclear research centres at Saclay and Cadarache were selected
together with the La Hague nuclear fuel-reprocessing plant.
Previous dose calculation work for the population living near the
La Hague reprocessing plant has been carried out in France
(GRNC, 1999; Laurier et al, 2000; Rommens et al, 2000). Only the
average dose delivered to the Beaumont-La Hague ‘canton’( a
geographic unit which, in this case, includes 10 ‘communes’) was
determined. No zoning was carried out to differentiate the
‘communes’.
For the NPPs, the average annual discharge levels and discharge
compositions for recent years were determined for each of the
two types of NPP, namely the 900MW and 1300MW NPPs. The
discharges from the 1450MW Chooz and Civaux NPPs were
assumed similar to the discharge from the 1300MW NPPs. The
typical composition of NPP gaseous discharges was taken into
account. The composition includes the following nuclides: tritium,
carbon 14, argon 41, krypton 85, xenon 133, xenon 135, iodine 131,
iodine 133, cobalt 58, cobalt 60, caesium 134 and caesium 137.
Carbon 14 was not measured in the gaseous effluent of the French
NPPs until very recently. Therefore, no discharge data on carbon
14 were available, and the levels were assumed equivalent to the
limit specified in recent discharge permits for this radionuclide.
The average discharge levels and compositions for a period of
several years (3- to 5-year period, depending on the data available)
were assessed for the other plants. Those levels and compositions
were assumed to be representative of discharges for recent years
(after 1995) and have been used as input data in the dose
estimations. Local climate data on wind speed and direction,
vertical stability of the atmosphere and rain frequency were used
for each site when available. Data were collected from the
documents submitted by operators in discharge authorisation
applications. For a few nuclear plants, data on vertical stability and
on rain frequency were not available and the national average data
were used.
The FOCON96 1.0 (Rommens et al, 1999) code was used to
calculate the doses from routine discharge into the atmosphere.
This code includes a model of gas and aerosol dispersion in the
atmosphere. The model is based on a Gaussian model with the
modelling of vertical and horizontal standard deviation developed
by Doury (1976). The code also includes models of dry and wet
deposition of aerosols on soil, grass and vegetable leaves. Wet
deposition is based on a model of plume scavenging by the rain.
The code takes into account root absorption of nuclides by
vegetables and grass. Contamination of meat and milk is also
modelled in the code. The default values of the transfer parameters
proposed in the FOCON 96 code have been used. The main
pathways have been taken into account: inhalation, ingestion
(vegetables, meat and milk), external exposure from the plume (in
the atmosphere or in the water) and deposits (aerosol deposition
on the ground and sediment deposition on beaches or river
banks). Protection by buildings was not taken into account in the
assessment of external exposure. National average food consump-
tion rates have been taken into account (INSEE, 1991). Only
estimates of the local part of food production were taken into
account (from national average data). It was assumed that 100% of
the year was spent in the ‘commune’. The dose coefficient to RBM
calculated by the International Commission of Radiological
Protection (2002) was used for internal pathways and the US
Federal Guidance dose coefficient for external exposure (Eckerman
and Ryman, 1993).
Red bone marrow doses from gaseous discharge were estimated
around each site on a polar grid (252 assessment points) around
the stack with the FOCON 96 code. The doses were interpolated on
a 250-m
2 mesh using a SPLINE method (G3GRID procedure of the
SAS
r software). The RBM dose for each ‘commune’ is the average
of the four nearest mesh points around the town-hall of the
‘commune’.
Areas under study
The studied area was defined as all ‘communes’ located in 40km
2
centred on 24 French nuclear installations. There are 36354
‘communes’ in France with an average population per ‘commune’
of 1609 people. A total of 2107 French ‘communes’ were included in
the study. A strict partition of the areas under study had to be
maintained in order to ensure the statistical independence of the
observations. Therefore, when study areas around two sites
overlapped (this occurred for 68 ‘communes’), the ‘communes’
were assigned to the site for which the estimated RBM dose was the
highest. The total RBM dose obtained by adding the RBM dose
estimates for the two sites was then assigned to the ‘commune’
considered. Since the Tricastin NPP and Pierrelatte plant are very
close to each other, they were considered as a single site
throughout the study. This explains the reference to 23 sites (18
NPPs) rather than the original 24 sites (19 NPPs). All of the 2107
‘communes’ were subsequently divided into five zones defined on
the basis of the estimated dose. Each of the lowest two categories of
estimated dose included approximately a tertile of the expected
number of cases in order to obtain stable incidence estimates in
each category. The corresponding arithmetic means were 0.021
and 0.057 microSievert per year (mSvy
 1) , respectively. In order to
cover the full range of variation of the estimated dose, the third
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scale. The corresponding arithmetic means were 0.141, 0.553 and
2.13mSvy
 1, respectively. Each of the five categories was
constructed as aggregations of the ‘communes’ whose estimated
dose was within the limits of the category.
Statistical analysis
The present study investigated for the existence of an increase in
the SIR of childhood leukaemia with increasing estimated
radiation dose due to gaseous discharge from nuclear sites. The
following four tests were used: Fisher’s w
2 test, the likelihood ratio
test, a linear risk score test, and Stone’s Poisson maximum test.
Fisher’s w
2 test and the likelihood ratio test based on the Poisson
regression models were used to examine the heterogeneity of the
five predefined categories of estimated dose. The linear risk score
test and Stone’s Poisson maximum test explicitly investigate for an
increase in SIR with increasing estimated dose. The linear risk
score test used was adapted from those used by Bithell et al (1994)
and discussed by Bithell (1995): for the test, each case is scored on
the basis on the estimated dose of the ‘commune’ under
consideration. The Stone’s Poisson maximum test is based on
the maximum value of the SIR as ‘communes’ ranked by increasing
estimated dose are aggregated into a region of greater size (Stone,
1988). The latter two tests were applied to the five predefined dose-
based categories and to the estimated dose considered quantita-
tively for each ‘commune’. The powers of the linear risk score tests
and Stone’s Poisson maximum test to detect a given risk pattern
have been discussed by several authors (Bithell, 1995; White-
Koning et al, 2004; COMARE, 2005).
For all four tests, both an external and an internal reference were
used. In the case of tests using an external reference, rejecting
the null hypothesis (i.e. a uniform SIR of 1 irrespective of the
estimated dose) might evidence the existence of a trend in the
relative risk with the estimated dose, or might be due to an excess
risk in the overall study area compared to the whole of France,
which was considered as the external reference in the study. Using
an internal reference enables only the distribution of cases within
the study area to be considered and ignores the difference between
the overall observed and expected numbers of cases around a
given site.
The 5% critical values and the P-values of the four test statistics
were estimated using simulation methods with R-software. Under
the null hypothesis of a uniform SIR of 1 irrespective of the
estimated dose, the null distributions of the four tests were
determined from 10000 simulations. The simulations were based
on a Poisson distribution with expected values equal to the
expected numbers of cases in the case of an external reference, or
on a multinomial distribution with expected values proportional to
the expected numbers of cases in the case of an internal reference.
The 5% critical values and the P-values were then derived from the
null distributions.
The analyses were performed for the 23 sites, for all cases (0–14
years) and for the complete period (1990–2001), and then
separately, by age group (0–4, 5–9 and 10–14 years), period
(1990–1995, 1996–2001), and leukaemia type (ALL, AML). The 18
NPPs were analysed as a separate subgroup because of their
common characteristics. The possible heterogeneity of the 23 sites
led to a more detailed study of each site individually. Bonferroni’s
method was used in order to correct for multiple testing.
RESULTS
The estimated doses due to gaseous discharge in the 2107
‘communes’ located in the vicinity of the 23 nuclear installations
ranged from 0.06 to 1.33mSvy
 1, with an arithmetic mean of
0.17mSvy
 1, and a standard deviation of 0.48mSvy
 1.
Table 1 shows the distribution of the observed and expected
numbers of childhood leukaemia cases and the SIRs by the above
dose-based categories, for each of the 23 nuclear sites, for the
18 NPPs considered together and for the 23 sites considered
together. The observed number of cases of childhood leukaemia
within the study area (O¼750) was lower than expected
(E¼795.01), but the difference was not statistically significant
(SIR¼0.94, 95% CI¼[0.88–1.01]). Considering all 18 NPPs or all
23 sites, no evidence of heterogeneity between the five dose-based
categories, and no trend toward an increase in SIR with increasing
estimated dose, considered qualitatively or quantitatively, were
found.
The likelihood ratio test and Fisher’s w
2 test showed significant
heterogeneity of the 23 nuclear sites (P¼0.025 and 0.027,
respectively). A statistically significant excess of cases was
observed for one plant (Chinon: O¼20, SIR¼1.83, 95%
CI¼[1.12–2.83]), and a statistically significant deficit of cases
was found for two plants (Fessenheim: O¼17, SIR¼0.50, 95%
CI¼[0.29–0.80]; Pierrelatte/Tricastin: O¼6, SIR¼0.41, 95%
CI¼[0.15–0.90]). When Bonferroni’s method was used to correct
for multiple testing (23 comparisons), neither the excess nor the
deficits remained significant.
The overall tests are largely influenced by the Saclay site, which
is located close to Paris and hence includes most of the cases.
Therefore, the main analyses were also carried out on the 22
remaining sites excluding Saclay. There were 292 cases of
childhood leukaemia compared to an expected number of 310.88
(SIR¼0.94, 95% CI¼[0.83–1.05]). No evidence of either hetero-
geneity between the five dose-based categories or a trend toward
an increase in SIR with increasing estimated dose considered
qualitatively or quantitatively, was found.
None of the 23 sites showed any statistical evidence of a SIR
trend with increasing estimated dose, or of heterogeneity between
the five dose-based categories. A likelihood ratio test based on
Poisson regression models did not show any statistically sig-
nificant heterogeneity for the slopes of the relationship between
estimated dose and childhood leukaemia incidence estimated for
each of the 23 sites separately (P¼0.46). The common estimation
of these slopes was not significantly different from 0: exp^ b¼0.83
per mSvy
 1 (95% CI¼[0.58–1.20]) where ^ b is the regression
coefficient associated to the estimated dose.
Table 2 shows the distribution of the observed and expected
numbers of childhood leukaemia cases and the SIRs by category
of estimated dose for age groups 0–4, 5–9 and 10–14 years. No
evidence of either heterogeneity between the five dose-based
categories or a trend towards an increase in SIR with increasing
estimated dose considered qualitatively or quantitatively, was
found for any of the three age groups, when all 18 NPPs, all 23 sites
or only 22 sites were considered.
There was no statistical evidence of heterogeneity between
the five dose-based categories or of a trend towards an increase in
SIR with increasing estimated dose, considered qualitatively or
quantitatively, for any of the periods (1990–1995, 1996–2001), or
for any of the leukaemia types (ALL, AML), when all 18 NPPs or all
23 sites were considered.
DISCUSSION
The observed number of cases of acute leukaemia (O¼750) in
40km
2 centred on the 23 French nuclear installations between
1990 and 2001 was lower than expected (E¼795.01), but not
significantly so (SIR¼0.94, 95% CI¼[0.88–1.01]). In none of the
five zones defined on the basis of the estimated dose due to
gaseous discharges was the SIR significantly greater than 1.0.
There was no evidence of an increasing trend in SIR with
increasing estimated dose for all children or for any of the three
age groups studied.
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on dose level order of magnitude using the same model for all
nuclear installations. Inaccurate dose estimation cannot be
excluded but since the same methodology was used for all sites,
if the model or generic parameters were erroneous, the estimated
doses would be uniformly raised or reduced; the geographic
zoning would thus remain similar and the trend results would be
unchanged. Conversely, inaccuracies related to the characteristics
of each site, especially those related to local climate data, may have
resulted in geographic zoning. However, climatologic data are
derived from multiyear measurements and are not likely to be
significantly inaccurate. The geographic zoning derived from dose
estimates used in the present study is therefore considered not to
be seriously erroneous. The dose estimates were based on a simple
method. In particular, discharge has been assumed to occur at
ground level for NPPs because the stacks are only a few meters
higher than buildings (wake effect on the plume). For NPPs,
insufficient data on the real discharge rates of carbon 14 were
available. In consequence, relatively high rates for the discharge
of carbon 14 by NPPs were assumed: the regulatory limits for
discharge rates. This is likely to overestimate the contribution of
carbon 14 to the estimated dose. The doses were estimated for
adults because a sensitivity analysis showed that the estimated
dose was rather similar for all the ages considered. The method of
dose estimation was based on recent discharge rate data from the
late nineties. As discharges generally show a sharp decrease with
time, these data may lead to an underestimation of the doses
compared to those associated to past discharges. On the other
hand, the data are characteristic of the period 1996–2000, which
approximately corresponds to the period of leukaemia diagnosis
(1990–2001).
Further contributions to the total dose of radiation may be taken
into account from direct radiation and liquid discharges. Direct
radiation is minor around the French nuclear installations and can
be neglected. Doses due to liquid discharges are possibly of the
same order of magnitude as those from gaseous discharges, but
may be considered homogeneous at the geographic scale used for
gaseous discharges. Liquid-discharge doses depend on factors that
are not subject to local borders, that is agricultural habits, food
harvesting and distribution channels, and individual behaviour
(bathing, fishing, consumption of food contaminated by irrigation
from waterways). In consequence, the doses from liquid discharges
Table 1 Distribution of observed (O) and expected (E) numbers of childhood leukaemia cases by category of estimated dose due to gaseous discharge in
the vicinity of each of 23 nuclear sites in France (1990–2001)
Estimated dose due to gaseous release (lSvy
 1)
No
o0.045 0.045–0.072 0.072–0.316 0.316–1.0 X1.0 Total
Nuclear sites (years
a) COM
b OEOEOEOEOEOE
Nuclear power plants:
Belleville (1987) 58 1 0.79 2 0.63 3 2.82 0 0.34 0 0.11 6 4.68
Bugey (1979) 132 9 8.46 6 5.11 15 10.70 1 1.11 0 0.39 31 25.77
Cattenom (1986) 122 4 1.48 1 1.92 13 14.83 6 8.69 0 0.58 24 27.50
Chinon (1987) 88 9 4.85 1 1.11 7 3.30 3 1.31 0 0.32 20 10.90
Chooz (1997) 22 1 0.52 0 0.30 1 0.51 0 0.07 0 0.03 2 1.44
Civaux (1999) 58 3 0.99 0 0.19 0 0.51 0 0.03 0 0.02 3 1.75
Cruas (1983) 93 7 4.83 1 0.43 4 2.69 2 1.98 2 3.34 16 13.26
Dampierre (1980) 51 2 0.77 0 1.50 4 3.12 0 0.49 0 0.15 6 6.02
Fessenheim (1977) 69 17 31.86 0 0.53 0 1.35 0 0.20 0 0 17 33.94
Flamanville (1985) 27 0 0.43 0 0.57 0 0.36 2 0.54 0 0.32 2 2.22
Golfech (1990) 110 1 2.32 1 3.57 2 3.40 1 0.52 0 0.54 5 10.35
Gravelines (1980) 63 7 12.05 2 1.35 19 18.75 1 4.66 1 1.49 30 38.30
Le Blayais (1981) 89 1 0.72 0 1.69 5 3.34 1 1.09 0 0 7 6.84
Nogent (1987) 121 2 2.84 0 2.23 1 1.78 2 0.90 0 0 5 7.75
Paluel (1984) 127 0 1.34 1 0.98 4 4.66 0 0.50 0 0.54 5 8.01
Penly (1990) 133 7 4.20 3 1.81 5 5.36 0 0.36 0 0.33 15 12.06
St Alban (1985) 143 16 16.18 1 1.62 8 7.84 3 2.28 0 0.32 28 28.24
St Laurent (1981) 77 12 7.87 3 2.47 4 3.08 1 0.47 0 0.11 20 13.99
Total NPPs 1583 99 102.49 22 28.03 95 88.39 23 25.54 3 8.58 242 253.03
SIR (95%CI) 0.97 (0.79–1.18) 0.78 (0.49–1.19) 1.07 (0.87–1.31) 0.90 (0.57–1.35) 0.35 (0.07–1.02) 0.96 (0.84–1.08)
Pierrelatte/Tricastin (1980) 78 2 4.10 0 1.66 3 6.26 1 2.45 0 0 6 14.47
Total NPPs+Pierrelatte/Tricastin 1661 101 106.59 22 29.69 98 94.65 24 27.99 3 8.58 248 267.49
SIR (95% CI) 0.95 (0.77–1.15) 0.74 (0.46–1.12) 1.04 (0.84–1.26) 0.86 (0.55–1.28) 0.35 (0.07–1.02) 0.93 (0.82–1.05)
Other sites:
Cadarache (1963) 47 7 6.18 1 0.90 3 1.52 0 0.14 0 0 11 8.74
La Hague (1967) 43 0 0 0 0 0 0 10 8.15 3 1.81 13 9.97
Romans-sur-Ise `re (1962) 114 20 24.68 0 0 0 0 0 0 0 0 20 24.68
Saclay (1950) 242 114 124.88 238 238.45 102 114.96 3 5.32 1 0.52 458 484.13
Subtotal (NPPs and other except Saclay) 1865 128 137.45 23 30.59 101 96.16 34 36.28 6 10.39 292 310.88
SIR (95% CI) 0.93 (0.78–1.11) 0.75 (0.48–1.13) 1.05 (0.86–1.28) 0.94 (0.65–1.31) 0.58 (0.21–1.26) 0.94 (0.83–1.05)
Total (NPPs and other) 2107 242 262.34 261 269.04 203 211.12 37 41.60 7 10.91 750 795.01
SIR (95% CI) 0.92 (0.81–1.05) 0.97 (0.86–1.10) 0.96 (0.83–1.10) 0.89 (0.63–1.23) 0.64 (0.26–1.32) 0.94 (0.88–1.01)
95% CI¼95% confidence interval for the SIR; SIR¼standardized incidence ratio¼O/E.
aFirst year of operation
bNumber of ‘Communes’.
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gaseous discharges are considered to classify ‘communes’ correctly.
Moreover, the results of the analyses were unchanged when the
type of environment (sea, river, pool, etc.) of the nuclear sites
under study was taken into account.
The epidemiological studies of the incidence of leukaemia
around nuclear sites analysed incidence as a function of the
distance from the sites. However, the dispersion of the radio-
nuclides is generally not isotropic, the estimated dose does not
decrease linearly with the distance and dose levels are not equal for
all sites. The method of zoning used in the present study enables
estimation of the real geographic distribution of the carcinogen
dose (ionising radiation) in the environment (Morin and Backe,
2002, 2003). The zones defined by dose assessments were very
different from concentric circles around the plants due to
topographic and meteorological characteristics (Morin and Backe,
2002, 2003). The estimated dose and distance were significantly
negatively correlated (Spearman’s rank correlation coefficient
r¼ 0.58, Po10
 4), but marked variability in the estimated dose
within each concentric band (0–5, 5–10, 10–15, 15–20km)
remained. The contrast in the mean dose between the lowest and
highest dose-based categories (range: 2.11mSvy
 1; ratio: 106) was
much larger than the maximum contrast between the concentric
bands 0–5 and 15–20km (range: 1.16mSvy
 1; ratio: 30).
The estimated dose attributable to gaseous discharge delivered
to the population was very small for all ‘communes’ located in
40km
2 centred on the nuclear sites considered (mean dose
o0.20mSvy
 1 and maximum value about a few microSievert per
year). According to current knowledge on the effects of exposure
to ionising radiation, no observable effect associated to such low
doses is expected (UNSCEAR, 2000). The absence of excess risk or
trend associated to the doses due to routine discharge from the
plants is not surprising. In comparison, the RBM dose due to
natural sources of exposure (including radon, terrestrial and
cosmic gamma radiation, and intake of natural radionuclides)
(Billon et al, 2005; Evrard et al, 2005, 2006) has been estimated to
be 2700mSvy
 1 for children, and the dose due to medical
examinations has been estimated to be approximately 740mSvy
 1
(Rommens et al, 2001). The mean estimated RBM dose due to
gaseous radioactive discharge for children living in the vicinity
of nuclear installations is therefore approximately 1000 to 10000
times lower than the mean RBM dose due to natural sources.
CONCLUSION
Most of the epidemiological studies of the incidence of leukaemia
around nuclear sites analysed incidence as a function of the
distance from the sites. In the present study, a dose-based zoning,
rather than distance, was used for the first time in order to
enhance the characterisation of the population’s exposure. This
approach has the advantage of considering the nonisotropic
distribution of gaseous discharges in the environment. It also
provides an illustration of the weakness of the doses due to routine
discharges compared to other sources of exposure to ionising
radiation. No evidence was found for a general increase or trend in
the incidence of childhood leukaemia according to this zoning in
the vicinity of the 23 French nuclear installations considered for
the period 1990–2001.
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